Release Date: 20/02/20 08:17 Summary: H1 FY20 Results Presentation Price Sensitive: Yes Download Document 2.77MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%